Skip to main content
SPRC
NASDAQ Life Sciences

SciSparc Achieves Conditional Nasdaq Compliance, Averting Immediate Delisting

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$6.198
Mkt Cap
$3.583M
52W Low
$2.98
52W High
$80.1
52W Position info
108% above low
Off High info
92% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

SPRC has more than doubled off its 52-week low of $2.98 on light trading volume (0.1× avg).

Summary

SciSparc Ltd. received a conditional compliance letter from Nasdaq, confirming it now meets the minimum stockholders' equity requirement, but faces potential delisting if future compliance is not maintained.


Key Events · Corporate Governance and Compliance · SPRC

  • Conditional Nasdaq Compliance Achieved

    Nasdaq determined SciSparc now complies with Rule 5550(b)(1) for minimum stockholders' equity, based on its Annual Report on Form 20-F filed on April 29, 2026.

  • Immediate Delisting Threat Averted

    This compliance temporarily resolves the immediate threat of delisting that the company faced since January 2026 due to not meeting Nasdaq's minimum stockholders' equity requirement.

  • Future Compliance Remains Critical

    The compliance is conditional; the company must provide evidence of continued compliance upon filing its next periodic report or it may be subject to delisting.


Analysis · SPRC · Life Sciences

This filing provides a crucial update on SciSparc's Nasdaq listing status. The company has successfully demonstrated compliance with the minimum stockholders' equity rule (5550(b)(1)), temporarily resolving a significant delisting threat that has been a recurring concern since January 2026. This follows previous efforts including a reverse stock split and dilutive financing. However, the compliance is conditional, meaning the company must maintain this status in its next periodic report to avoid further delisting actions. This indicates ongoing financial fragility despite the immediate reprieve.

At the time of this filing, SPRC was trading at $6.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.6M. The 52-week trading range was $2.98 to $80.10. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SPRC - Latest Insights

SPRC
Aug 05, 2026, 8:22 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.96
Real-time Price: $6.91 info
Change: -$1.05 (-13%) info
Market Cap: $3.961M info
SPRC
Jul 31, 2026, 8:20 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.71
Real-time Price: $6.91 info
Change: -$0.802 (-10%) info
Market Cap: $3.961M info
SPRC
Jul 15, 2026, 8:41 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.66
Real-time Price: $6.91 info
Change: +$2.25 (+48%) info
Market Cap: $3.961M info
SPRC
Jun 22, 2026, 1:46 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $6.93
Real-time Price: $6.91 info
Change: -$0.020 (-0.29%) info
Market Cap: $3.961M info
SPRC
Jun 03, 2026, 5:15 PM EDT
Source: TheNewswire
Importance Score:
7
Price at Filing: $9.45
Real-time Price: $6.91 info
Change: -$2.54 (-27%) info
Market Cap: $3.961M info